AstraZeneca, Cumberland Pharmaceuticals, Pieris, Theraptosis and
InteKrin Therapeutics have all had people on the move in the world
of pharmaceutical manufacturing.
Parexel has purchased a clinical research organisation (CRO) in
Taiwan as a means to exert its presence in this industry's budding
Asia-Pacific region.
Swedish speciality pharma company Meda AB has announced its new low
dose of Soma (carisoprodol) has been approved by the US Food and
Drugs Administration (FDA).
Some of the world's largest pharma firms have set out what
therapeutic areas and specific mechanisms are becoming more
important to them, and which will be left by the wayside.
Start-up UK biotech firm Circassia technology has had a major
result in bagging 30-year industry veteran and former
GlaxoSmithKline (GSK) chairman, Sir Richard Sykes, as its new
chairman of the board.
A new living cell-based skin graft technology is being hailed by
its inventors as a 'clinical breakthrough in regenerative medicine'
following early-stage trial results, published yesterday.
The contract manufacturing business that Cardinal Health sold
earlier this year has just been launched as an independent
operating company rebranded as Catalent Pharma Solutions.
US company Alnylam Pharmaceuticals has consolidated its
relationship with researchers from the Massachusetts Institute of
Technology (MIT) by signing an agreement to sponsor a five-year
program at the Institute's Center for Cancer...
Pharmatek has moved to a new larger lab and manufacturing facility
while Pace Analytical Life Sciences recently acquired lab testing
firm P3 Scientific.
In-PharmaTechnologist.com and Outsourcing-Pharma.com journalist
Kirsty Barnes has received the honour of being announced among the
place winners of the 2006 Awards for Excellence in Health Care
Journalism (AHCJ).
The French Parliament has adopted legislation which prevents
biosimilar medicinal products from being classed as generics and
bans the automatic substitution of one biological medicine for
another.
Cardinal Health is about to sell its drug manufacturing arm to an
international private investment firm, only two months after
announcing its decision to divest the segment, while its second
quarter earnings doubled as a result.
The move towards electronic files is set to bring major benefits in
the clinical trials area especially in terms of patient
recruitment, new research suggests.
Pharma company Medichem has announced it has passed a US Food and
Drug Administration (FDA) inspection without any problem for the
third consecutive time.
France has placed itself firmly at the forefront of research into
personalised medical solutions for cancer, infectious diseases and
rare genetic diseases by investing nearly half a billion euros into
the ADNA project.
DSM Venturing, the investment arm of the Dutch chemical giant, has
announced it has snapped a 10 per cent share in pharma materials
provider Micromuscle.
Dragon International has announced its plans to acquire Jinguang
Pharmaceuticals, a manufacturer of Chinese herb medicines, in a bid
to get a first step into the burgeoning traditional Chinese herbal
medicine market.
IntegraGen has made significant waves in the area of personalised
healthcare announcing a collaborative with the DSM Personalised
Nutrition Group and a €2m equity investment by DSM Venturing.
Ground Zero Pharmaceuticals (GZP) has announced an expansion to the
services it offers enabling the expansion into more of its clients'
late-stage development programs, with the potential for creating
submissions that lead to...
US contract pharmaceutical manufacturer Metrics has announced a
$17.5m (€13.7m) investment to double the size of its drug testing
and manufacturing plant over the next three years.
Cardinal Health has been given the green light from the US Food and
Drug Administration (FDA) to start manufacturing the first
commercial drug at its new sterile facility in North Carolina.
According to the CEO and Chairman of pharmaceutical giant Eli
Lilly, the biomedical breakthroughs that are occurring within the
industry are transforming medicine and promise to ease the
challenges facing an aging population.
Archemix has announced the formation of a strategic alliance with
Elan to discover and develop first-in-class aptamer therapeutics to
treat autoimmune disease.
Two French clinical research organisations (CROs), PharmaScan and
ClinicalLand, have joined forces to accelerate their growth and
reinforce their presence in the competitive clinical trials sector.
Medical technology company e-pill has unveiled a new automated pill
dispenser which delivers medications at the right time and in the
right amount, ensuring compliance.
After recently opening up shop in nearby Singapore, SGS has now
brought its contract testing services to neighbouring China to
continue to cash in on the demand for such services in the
Asia-Pacific region.
Bioprogress has signed a development agreement with emerging
speciality pharmaceutical company Uluru to combine their film
technologies in order to create an edible film which allows
sustained release of active ingredients.
Chronic diseases account for 70 per cent of the healthcare budget
in the UK alone. New drugs in unment chronic disease areas offer
real blockbuster potential for companies willing to take on the
challenge.
The possibility of a new class of anti-inflammatory compounds that
exhibit broad action across multiple therapeutic sites could be on
the horizon after Reata announced the completion of a license
agreement for these drug candidates...
According to a new report, the pharmaceutical market grew seven per
cent, to $602 billion (€501 billion) in 2005. The report
highlighted the emerging markets including China, Korea, Mexico,
Russia and Turkey, which experienced double-digit...
The Pharmaceutical Institute, provider of specialised knowledge for
the pharma industry, is now providing custom research services to
cater for those with complex research needs.
Medidata Solutions, a global provider of e-clinical data capture,
management and reporting solutions, benefited from the drive from
paper to electronic technology in clinical trials, picking up
several lucrative contracts and expanding...
FEI and Sidec have entered into an agreement to commercialise a
range of Protein Tomography solutions that could provide drug
companies with services that could increase the chances of success
in early stage drug development.
A new laboratory test, which enables the rapid diagnosis of urinary
tract infections with novel biosensor technology, has proved so
successful that it may replace antiquated testing methods, saving
health care costs and valuable diagnosis...
Emerging biopharmaceutical company, Align Pharmaceuticals, has
enlisted sales and marketing services provider, PDI, to provide a
40-person sales force for its three newly acquired oncology
products.
According to a new report, technical advances in the R&D
environment have promoted the uptake of biochips in clinical
research applications. However, the report identified the high
prices as a prime area of concern.
International Isotopes has announced the renewal of an existing
contract manufacturing agreement, which aims to continue the
production of nuclear medicine calibration and reference standards.
VirtualScopics reported a breakthrough year in 2005, doubling its
customer base to 26 and reaping in more than $5 m (€4.1 m) worth of
business, an increase from the previous year of over 100 per cent.
Johns Hopkins researchers have devised a self-assembling
cube-shaped perforated container, which may serve as a delivery
system for medications and cell therapy that can easily be tracked
via MRI.
The first diagnostic test available for the confirmation of chronic
sinusitis (CS) disease has been made available by Accentia
Biopharmaceuticals, which will assist in the identification of a
problem that affects an estimated 31 million...
Hopax Fine Chemicals is building a new facility in Kaohsiung,
Taiwan, in a move to raise current production capacity by five
folds and become one of the top providers for biological buffers
and specialty chemicals for the pharmaceutical...
